Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Update

Starpharma Holdings Limited (OTCMKTS:SPHRY) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 4,500 shares, a decline of 18.2% from the June 30th total of 5,500 shares. Based on an average daily volume of 400 shares, the short-interest ratio is presently 11.3 days.

Starpharma Stock Performance

OTCMKTS:SPHRY remained flat at $0.56 during mid-day trading on Monday. Starpharma has a 1 year low of $0.56 and a 1 year high of $2.81. The company’s 50 day moving average price is $0.67 and its two-hundred day moving average price is $0.82.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.